2007
What do we get for our money? Cost‐effectiveness of adding contingency management
Sindelar J, Elbel B, Petry NM. What do we get for our money? Cost‐effectiveness of adding contingency management. Addiction 2007, 102: 309-316. PMID: 17222286, DOI: 10.1111/j.1360-0443.2006.01689.x.Peer-Reviewed Original ResearchAdolescentAdultAgedCocaine-Related DisordersCost-Benefit AnalysisFemaleHumansMaleMethadoneMiddle AgedMotivationNarcotics
2004
Cost effectiveness of disulfiram Treating cocaine use in methadone-maintained patients
Jofre-Bonet M, Sindelar JL, Petrakis IL, Nich C, Frankforter T, Rounsaville BJ, Carroll KM. Cost effectiveness of disulfiram Treating cocaine use in methadone-maintained patients. Journal Of Substance Use And Addiction Treatment 2004, 26: 225-232. PMID: 15063917, PMCID: PMC3662046, DOI: 10.1016/s0740-5472(04)00004-2.Peer-Reviewed Original ResearchConceptsMethadone treatmentClinical trialsCocaine useDouble-blind clinical trialCocaine dependenceStandard methadone treatmentBlind clinical trialMethadone-maintained patientsRandomized clinical trialsOpioid-dependent subjectsMethadone-maintained opiate addictsStandard treatmentOutcome measuresOpioid addictsPromising treatmentOpiate addictsIncremental costDisulfiramAdditional treatmentNumber of daysTrialsTreatmentCost effectivenessEconomic evaluationAddicts